External resources Phase 2 trial: Once-weekly cagrilintide for weight management (PubMed) REDEFINE 1: Coadministered cagrilintide and semaglutide in adults with overweight or obesity (NEJM) Development of cagrilintide, a long-acting amylin analogue (Journal of Medicinal Chemistry) For researchers serious about building evidence-based peptide protocols, SeekPeptides offers the most comprehensive resource available
Weight loss is a partnership between medication and behavior
Hot liquids can cause temporary inflammation
SGLT2 inhibitors generally offer superior renal protection and are recommended for patients with chronic kidney disease
Methylcobalamin formulations typically cost $15-30 more monthly
Gut microbial mHyal can remodel intestinal microbiota by enriching short-chain fatty acid (SCFA)-producing bacteria (e.g., Bifidobacterium), suggesting therapeutic potential for bacterial colitis [62,63,64,65,66]